Find policies, billing codes, payers, states, and providers
CPT 32488: Removal of Remaining Lung Tissue After Prior Lobectomy/Segmentectomy
CPT code 32488 denotes a completion pneumonectomy: surgical removal of the remaining lung tissue in a patient who previously had a lobectomy or segmentectomy on that lung. This is a major thoracic operation often performed when residual disease, recurrent tumor, or other complications necessitate removal of the remaining hemithorax. Nationally, completion pneumonectomy is clinically significant because it carries substantial perioperative risk, potential for extended inpatient recovery, and important implications for coding, payment, and quality reporting.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of procedural intent and typical settings of care, plus reporting guidance relevant to billing teams and clinical administrators. The publication outlines benchmarks and utilization context where available, summarizes policy and coding considerations for each payer, and provides clinical context that affects site-of-service decisions and resource use. Data not available in the input is noted where applicable. The content is intended to inform revenue cycle, coding staff, and clinical leaders about the definition, clinical role, and payer landscape for CPT code 32488 at a national level.
Customize your policy alerts
Sign up for cpt 32488 policy alerts
Get alerted when payer policies referencing 32488 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 32488 describes the surgical removal of the remaining lung tissue in a patient who previously underwent a lobectomy or segmentectomy of that same lung. This procedure completes a prior partial lung resection by performing a completion pneumonectomy of the affected side.
-
Service type: Major thoracic surgical procedure
-
Typical site of service: Hospital operating room (inpatient or outpatient surgical setting depending on clinical indication and patient status)